Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Treatment response
| Response a | Tarextumab + nab‐paclitaxel + gemcitabine (n = 89) | Placebo + nab‐paclitaxel + gemcitabine (n = 88) |
|---|---|---|
| Overall response rate | 18 (20%) | 28 (32%) |
| Partial response | 18 (20%) | 28 (32%) |
| Stable disease | 31 (35%) | 36 (41%) |
| Progression of disease (POD) | 21 (24%) | 6 (7%) |
| Not Evaluable | — | 1 (1%) |
| Clinical POD (no follow up imaging) | 19 (21%) | 17 (19%) |
Per RECIST v1.1
